Abvc Biopharma (ABVC) Price to Earnings (2024 - 2025)
Abvc Biopharma's Price to Earnings was 10.45 in Q3 2025, up 114.3% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Price to Earnings (2024 - 2025) Analysis & Trends
For FY2024, Price to Earnings at Abvc Biopharma came in at 1.56.
- Per Business Quant data, ABVC's Price to Earnings in the three quarters before Q3 2025 was 4.88 (Q2 2025), 1.61 (Q1 2025) and 1.31 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 10.45 |
| Jun 30, 2025 | 4.88 |
| Mar 31, 2025 | 1.61 |
| Dec 31, 2024 | 1.31 |
API Access
Abvc Biopharma Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();